Dr. Kemka S. Ogburia Jr., MD

Dr. Ogburia practices at Gastro Health Ambulatory Endoscopy Center of Central Florida in Longwood, Florida.

Dr. Ogburia's NPI, 1275710758, was assigned on January 27, 2008. Dr. Ogburia graduated from Frederick P. Whiddon College of Medicine in 2002. Dr. Ogburia holds Florida license ME101561.

Dr. Ogburia's primary practice is Gastro Health Ambulatory Endoscopy Center of Central Florida, at 515 W Sr 434 #105, Longwood, FL 32750. The practice phone is (407) 260-6000.

Dr. Ogburia's primary practice is Gastro Health Ambulatory Endoscopy Center of Central Florida in Longwood, Florida. Dr. Ogburia is also affiliated with AdventHealth Waterman. The medical group on file is The Dermatology Group, P.A. Dmand AI also links Dr. Ogburia to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogburia practices, 4 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Ogburia's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Ogburia is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ogburia's licenses on file in 5 states: Florida, Illinois, District of Columbia, Virginia and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Ogburia treats.

CMS data shows 6,496 Medicare services from Dr. Ogburia across 46 procedure codes in 2024, for 1,106 Medicare patients. Medicare paid $1,556,974 for them. Every service was in an office.

CMS counts 1,106 Medicare patients who saw Dr. Ogburia in 2024. The largest group is 75 to 84, with 501 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ogburia's median patient age at 76, with 49% women.

In 2024, Dr. Ogburia wrote 961 Medicare Part D claims for 620 patients. 99% of them were for generic drugs. CMS names the drug for 897 of them, across 10 drugs with 11 or more claims each, at $9,456 in total drug cost. In 2023, CMS named 989 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ogburia for performance year 2024, reported as part of a group. Dr. Ogburia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 310 procedures of melanoma (skin cancer) excision by Dr. Ogburia, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Ogburia.

CMS Open Payments shows 82 general payments to Dr. Ogburia from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $568.

Dr. Ogburia graduated from Frederick P. Whiddon College of Medicine in 2002.

Dr. Ogburia is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.